Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice

Atherosclerosis and related cardiovascular diseases represent the greatest threats to human health, worldwide. Previous animal studies showed that selenium nanoparticles (SeNPs) and Na<sub>2</sub>SeO<sub>3</sub> might have anti-atherosclerotic activity, but the underlying mec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junying Xiao, Na Li, Shengze Xiao, Yuzhou Wu, Hongmei Liu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b05af31ca39b43b096f8f2e15e31b0b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b05af31ca39b43b096f8f2e15e31b0b8
record_format dspace
spelling oai:doaj.org-article:b05af31ca39b43b096f8f2e15e31b0b82021-11-11T17:05:19ZComparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice10.3390/ijms2221116121422-00671661-6596https://doaj.org/article/b05af31ca39b43b096f8f2e15e31b0b82021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11612https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Atherosclerosis and related cardiovascular diseases represent the greatest threats to human health, worldwide. Previous animal studies showed that selenium nanoparticles (SeNPs) and Na<sub>2</sub>SeO<sub>3</sub> might have anti-atherosclerotic activity, but the underlying mechanisms are poorly elucidated. This study compared the anti-atherosclerotic activity of SeNPs stabilized with chitosan (CS-SeNPs) and Na<sub>2</sub>SeO<sub>3</sub> and the related mechanism in a high-fat-diet-fed apolipoprotein E-deficient mouse model of atherosclerosis. The results showed that oral administration of both CS-SeNPs and Na<sub>2</sub>SeO<sub>3</sub> (40 μg Se/kg/day) for 10 weeks significantly reduced atherosclerotic lesions in mouse aortae. Mechanistically, CS-SeNPs and Na<sub>2</sub>SeO<sub>3</sub> not only alleviated vascular endothelial dysfunction, as evidenced by the increase of serum nitric oxide level and the decrease of aortic adhesion molecule expression, but also vascular inflammation, as evidenced by the decrease of macrophage recruitment as well as the expression of proinflammatory molecules. Importantly, these results were replicated within in-vivo experiments on the cultured human endothelial cell line EA.hy926. Overall, CS-SeNPs had a comparable effect with Na<sub>2</sub>SeO<sub>3</sub> but might have more potential in atherosclerosis prevention due to its lower toxicity. Together, these results provide more insights into the mechanisms of selenium against atherosclerosis and further highlight the potential of selenium supplementation as a therapeutic strategy for atherosclerosis.Junying XiaoNa LiShengze XiaoYuzhou WuHongmei LiuMDPI AGarticlesodium seleniteselenium nanoparticlesatherosclerosisinflammationendothelial dysfunctionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11612, p 11612 (2021)
institution DOAJ
collection DOAJ
language EN
topic sodium selenite
selenium nanoparticles
atherosclerosis
inflammation
endothelial dysfunction
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle sodium selenite
selenium nanoparticles
atherosclerosis
inflammation
endothelial dysfunction
Biology (General)
QH301-705.5
Chemistry
QD1-999
Junying Xiao
Na Li
Shengze Xiao
Yuzhou Wu
Hongmei Liu
Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
description Atherosclerosis and related cardiovascular diseases represent the greatest threats to human health, worldwide. Previous animal studies showed that selenium nanoparticles (SeNPs) and Na<sub>2</sub>SeO<sub>3</sub> might have anti-atherosclerotic activity, but the underlying mechanisms are poorly elucidated. This study compared the anti-atherosclerotic activity of SeNPs stabilized with chitosan (CS-SeNPs) and Na<sub>2</sub>SeO<sub>3</sub> and the related mechanism in a high-fat-diet-fed apolipoprotein E-deficient mouse model of atherosclerosis. The results showed that oral administration of both CS-SeNPs and Na<sub>2</sub>SeO<sub>3</sub> (40 μg Se/kg/day) for 10 weeks significantly reduced atherosclerotic lesions in mouse aortae. Mechanistically, CS-SeNPs and Na<sub>2</sub>SeO<sub>3</sub> not only alleviated vascular endothelial dysfunction, as evidenced by the increase of serum nitric oxide level and the decrease of aortic adhesion molecule expression, but also vascular inflammation, as evidenced by the decrease of macrophage recruitment as well as the expression of proinflammatory molecules. Importantly, these results were replicated within in-vivo experiments on the cultured human endothelial cell line EA.hy926. Overall, CS-SeNPs had a comparable effect with Na<sub>2</sub>SeO<sub>3</sub> but might have more potential in atherosclerosis prevention due to its lower toxicity. Together, these results provide more insights into the mechanisms of selenium against atherosclerosis and further highlight the potential of selenium supplementation as a therapeutic strategy for atherosclerosis.
format article
author Junying Xiao
Na Li
Shengze Xiao
Yuzhou Wu
Hongmei Liu
author_facet Junying Xiao
Na Li
Shengze Xiao
Yuzhou Wu
Hongmei Liu
author_sort Junying Xiao
title Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
title_short Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
title_full Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
title_fullStr Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
title_full_unstemmed Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
title_sort comparison of selenium nanoparticles and sodium selenite on the alleviation of early atherosclerosis by inhibiting endothelial dysfunction and inflammation in apolipoprotein e-deficient mice
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b05af31ca39b43b096f8f2e15e31b0b8
work_keys_str_mv AT junyingxiao comparisonofseleniumnanoparticlesandsodiumseleniteonthealleviationofearlyatherosclerosisbyinhibitingendothelialdysfunctionandinflammationinapolipoproteinedeficientmice
AT nali comparisonofseleniumnanoparticlesandsodiumseleniteonthealleviationofearlyatherosclerosisbyinhibitingendothelialdysfunctionandinflammationinapolipoproteinedeficientmice
AT shengzexiao comparisonofseleniumnanoparticlesandsodiumseleniteonthealleviationofearlyatherosclerosisbyinhibitingendothelialdysfunctionandinflammationinapolipoproteinedeficientmice
AT yuzhouwu comparisonofseleniumnanoparticlesandsodiumseleniteonthealleviationofearlyatherosclerosisbyinhibitingendothelialdysfunctionandinflammationinapolipoproteinedeficientmice
AT hongmeiliu comparisonofseleniumnanoparticlesandsodiumseleniteonthealleviationofearlyatherosclerosisbyinhibitingendothelialdysfunctionandinflammationinapolipoproteinedeficientmice
_version_ 1718432197066620928